CTi
Designação definitivamente arquivada
Marca Mista depositada no INPI em
26/01/2022 por CTI Biopharma Corp.,
processo nº 501651091, nas classes 05, 16, 42, 44.
O processo não está mais ativo — o nome pode estar livre para novo pedido.
| Número do processo | 501651091 |
|---|
| Situação | Designação definitivamente arquivada |
|---|
| Apresentação | Mista |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 26/01/2022 |
|---|
| Data da concessão | — |
|---|
| Vigência até | 26/01/2022 |
|---|
| Titular | CTI Biopharma Corp. |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · US |
|---|
Classes e especificação
Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens.;
Brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms, patient support and community building.;
Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development.;
Providing healthcare information regarding disease states and treatments to healthcare professionals and patients.;